G. Rocha et al., NITRIC-OXIDE AND TRANSFORMING GROWTH-FACTOR-BETA LEVELS DURING EXPERIMENTAL UVEITIS IN THE RABBIT, Canadian journal of ophthalmology, 32(1), 1997, pp. 17-24
Objective: To determine changes in the levels of nitric oxide metaboli
tes and transforming growth factor-beta (TGF-beta) in the rabbit aqueo
us humour during ocular inflammation. Design: Active experimental uvei
tis was induced by injection of porcine lens protein (PLP) in three ra
bbits and of human serum albumin (HSA) in three rabbits; three control
rabbits received an injection of saline. Outcome measures: Degree of
inflammation, antibody titres (determined with the enzyme-linked immun
osorbent assay), and aqueous humour levels of nitric oxide metabolites
and TGF-beta. A modified Griess assay for nitrites and nitrates (NO2-
and NO3-) was used as a measure of nitric oxide generation, and a mod
ification of the CCL-64 mink lung epithelial cell bioassay was used to
quantify TGF-beta levels. Results: Following the primary immunologic
challenge both experimental groups initially showed a two- to fourfold
increment in aqueous levels of nitric oxide metabolites and TGF-beta
compared with baseline values. At the peak of the clinically observed
inflammation there was a significant increase in the mean nitric oxide
metabolite level compared with the control value (p less than or equa
l to 0.005) (432 nmol/mL for the PLP group and 112 nmol/mL for the HSA
group) and a significant decrease (p less than or equal to 0.03) in t
he mean TGF-beta level (3.1 ng/mL and 0.3 ng/mL respectively). Conclus
ions: Nitric oxide may be used as a marker for intraocular inflammatio
n. The increased production of nitric oxide may reflect the loss of im
munologic privilege of the ocular microenvironment that occurs during
inflammation.